Parallax Volatility Advisers, L.P. Axsome Therapeutics, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $1.66 Million - $3.21 Million	46,000 New	46,000 $2.05 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $1.03 Million - $2.04 Million	-20,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $852,840 - $2.1 Million	20,700 New	20,700 $1.22 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $215,360 - $412,000	-16,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $42,080 - $261,440	16,000 New	16,000 $228,000

327

37.8M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.94B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.